Two Hurdle Rates, One Truth: Why Valuation Is Really About Perspective

Jul 07, 2026

11 min read

2 views

91%

The Hidden Question Behind Every Valuation

What is an asset worth if the answer changes depending on who is asking?

That is the quiet tension at the heart of valuation. One framework asks what a business or asset must earn to justify itself. Another asks what an investor must earn to justify paying for it. They can point to the same company, the same future, even the same cash flows, yet produce different numbers because they are solving different problems.

This is not a flaw in finance. It is the point.

Valuation is often treated as if it were a single objective truth, hidden somewhere in the spreadsheet if only we discount carefully enough. But the deeper reality is more interesting: value is always negotiated between what an asset can produce and what a buyer needs to believe. The first is a question of economic substance. The second is a question of capital, risk, and timing. The distance between them is where deals are made, rejected, or overpriced.

And once you see that, a strange but useful connection appears. The same mental move is required in a very different domain: capturing a remote podcast. You can record content in a way that is technically possible, or in a way that is actually useful. One tool gives you a fast, web-based path. Another gives you a more controlled, higher-fidelity option. The choice is not just about recording audio. It is about who bears the risk, what quality standard you need, and how much friction you can tolerate.

That is the deeper shared lesson here: good decisions depend on choosing the right lens for the job, not the most sophisticated lens available.

The Asset Lens: What Must This Thing Earn to Deserve Capital?

When you use WACC, Weighted Average Cost of Capital, you are speaking from the perspective of the asset or the company itself. The question is not, “What return does a specific investor want?” The question is, “What minimum return must this business generate to satisfy the people who financed it?”

That makes WACC a kind of corporate gravity. It pulls future cash flows back into the present and asks whether they are enough to justify the capital already committed, or the capital that might be committed to a new project.

This is why WACC works naturally in discounted cash flow analysis. A business is not just a price tag, it is a machine for converting inputs into future free cash flow. If those cash flows, discounted at the right rate, exceed the cost of capital, then the project creates value. If not, it consumes it.

A biotech asset with high uncertainty may justify a high WACC, because the relevant question is not only profitability, but whether the operating risk is high enough to demand a higher hurdle. In this sense, WACC is a discipline against wishful thinking. It forces you to ask whether the business can stand on its own economic feet.

WACC is not a prediction of what investors will pay. It is a judgment about what the asset must earn to be worth owning at all.

That distinction matters. A company can be economically sound and still be uninvestable at a particular price. Conversely, a company can be underpriced relative to its future cash generation and still fail to attract capital if investors require much more upside than the asset can plausibly deliver.

The asset lens is therefore about intrinsic worth. It tells you what the thing is, financially speaking, before anyone tries to negotiate over it.

The Investor Lens: What Must I Earn to Make This Deal Rational?

Now switch perspectives. The Target IRR in a venture capital method is not asking what the company owes its financiers in some abstract sense. It is asking what one investor needs from this investment to make the risk worthwhile.

Here the future is compressed into a single exit event, or a few possible exits. Instead of projecting operating cash flows directly, the investor imagines a future sale, acquisition, or IPO, then discounts that exit value back to today using a return target set by fund structure, risk appetite, stage, and market conditions.

This is a very different kind of logic. The company lens says: “Show me the cash flow path.” The investor lens says: “Show me the payoff I need if the path works.”

The difference is not subtle. A venture investor is not primarily buying current earnings. They are buying a probability distribution. Many investments will fail, some will stagnate, and a few must return enough to pay for the whole portfolio. That is why target IRRs are often so high in pre-seed and seed stages. Illiquidity, binary risk, and long timelines all demand more compensation.

Think of it like hiking with a group where only a few people know the trail. One person is asking, “How much energy does the mountain require?” Another is asking, “How much energy do I personally need to justify making this climb?” The mountain is the same. The economics are not.

This is why investor pricing can diverge sharply from intrinsic value. A project may be worth a great deal in operational terms, yet still not fit the return math of a fund that needs outsized exits. Conversely, a highly speculative project might attract capital if the entry price is low enough to make the upside attractive enough.

The investor lens does not ask whether the asset is valuable in principle. It asks whether the expected path to realization is valuable enough for me, at this price, with my constraints.

That is a fundamentally different question from the one WACC answers.

Why These Two Lenses Are Not Competing, but Complementary

At first glance, WACC and Target IRR can look like rival valuation methods. In practice, they are best understood as two coordinate systems for the same terrain.

WACC is inward facing. It helps answer whether the asset, on its own terms, creates economic value. Target IRR is outward facing. It helps answer whether a particular investor can justify entering the deal. One is about business truth. The other is about capital market truth.

The trap is to treat either one as sufficient by itself.

If you use only WACC, you may end up with a valuation that is theoretically elegant but commercially irrelevant. You can discover that an asset has positive NPV while still failing to answer the decisive question: will anyone fund it at this price, under these terms, in this market?

If you use only Target IRR, you may end up with a valuation that reflects investor appetite more than business reality. You might discount a promising asset so aggressively that you confuse venture scarcity with intrinsic weakness.

This is where the synthesis becomes powerful. The two methods are not redundant. They illuminate different sources of truth:

Economic truth: Can the asset generate enough cash to justify its capital?
Portfolio truth: Can this investment produce enough upside to compensate for failure risk across a fund?
Negotiation truth: Where do those two truths overlap in a price both sides can live with?

That overlap is not a point. It is a range.

And in early-stage markets, especially in biotech or deep tech, the range may be wide because future cash flows are difficult to forecast and exit outcomes are highly uncertain. In such contexts, valuation should be seen less as a single answer and more as a structured disagreement about future states of the world.

A Better Mental Model: The Valuation Triangle

To make this practical, it helps to think in terms of a Valuation Triangle with three corners.

1. Asset Capacity

What can the business or asset realistically produce if things go well?

This is the WACC and DCF corner. It forces discipline around operations, milestones, market size, gross margins, and timing. If the asset cannot plausibly generate the projected cash flows, no amount of investor enthusiasm should rescue the model.

2. Investor Appetite

What return does the capital source need given the stage, risk, and liquidity profile?

This is the Target IRR corner. It recognizes that capital is not neutral. A pension fund, a biotech VC, and a strategic acquirer will not price the same company the same way because they each solve different optimization problems.

3. Market Narrative

What story can be believed by the next buyer, partner, or public market?

This corner is often underappreciated, yet it is decisive in early-stage valuation. A company can have strong projected cash flows and still struggle if no credible exit narrative exists. Venture capital valuation is not only about current promise, but about whether that promise can be translated into future market belief.

The most useful valuation work happens where these three corners intersect. That intersection is not purely mathematical. It is strategic.

A company with strong asset capacity but weak investor appetite may need different financing, a lower burn rate, or a longer runway. A company with strong investor appetite but weak asset capacity may be overhyped. A company with both, but no plausible market narrative, may still fail to raise at the intended price.

This triangle also explains why valuation debates are often so frustrating. People think they disagree about numbers when they really disagree about which corner matters most.

The Remote Recording Analogy: Choosing the Right Tool for the Right Risk

Now consider the podcast example. If you are recording remotely, you can use a web-based platform like Zencastr, Squadcast, or Zoom, or you can use a handheld recorder such as a Zoom H6 or H5.

That choice is not simply about technology preference. It is about the kind of failure you are willing to accept.

A web-based platform is fast, convenient, and accessible. It lowers friction, just as a simple investor-return framework can lower the friction of a quick funding decision. But if the internet connection stutters, you may lose quality. The method is efficient, but it depends on the environment.

A handheld recorder is more controlled and often higher fidelity, but it demands more setup, more discipline, and more cost. It resembles a deeper asset-based valuation: more work, more detail, more robustness, but also more time and specialization.

Here is the key connection: the right tool is the one that matches the risk you are managing.

If you are recording a casual interview, convenience may matter more than perfection. If you are capturing a flagship episode, the added reliability is worth the effort. Likewise, if you are pricing a mature business with stable cash flows, a standard DCF may be enough. If you are pricing an early-stage company whose value depends on a future exit and multiple contingencies, an investor-centered method may be more realistic.

In both cases, the temptation is to ask which method is universally better. That is the wrong question. The right question is which method is better for the failure mode you fear most.

The Real Skill Is Not Calculation, It Is Perspective Switching

Most people think valuation is a math problem. It is not. It is a perspective problem.

The numbers matter, but only after you have decided whose future you are modeling. The company’s future cash generation and the investor’s required return are not interchangeable, because they encode different risks, time horizons, and incentives. A spreadsheet can hide that difference if you are not careful.

The best analysts know how to switch lenses without confusing them.

They can ask, in sequence:

What is the intrinsic cash-generating power of this asset?
What return does the capital source require to make the risk worthwhile?
What constraints, narratives, and market conditions determine whether the two can meet?

That sequence matters because it prevents a common mistake: confusing a deal that is attractive to an investor with a business that is valuable, or confusing a business that is valuable with a deal an investor should make.

This also explains why serious negotiations often feel like two people speaking slightly different dialects of the same language. One side is anchored in enterprise economics. The other is anchored in portfolio economics. Neither is wrong. But unless both sides explicitly name their perspective, they will keep talking past each other.

Valuation becomes clearer when you stop asking, “What is it worth?” and start asking, “Worth to whom, under what future, and at what level of risk?”

That is not just a semantic improvement. It is the difference between a brittle estimate and a durable decision framework.

Key Takeaways

Always identify the perspective first. Before choosing a valuation method, ask whether you are pricing the asset itself or pricing an investment in the asset.
Use WACC for intrinsic economics, not investor psychology. It is best for asking whether projected cash flows justify the capital invested in the business or project.
Use Target IRR for deal discipline. It is best for asking whether the expected exit can produce enough upside for a particular investor with specific return requirements.
Treat valuation as a range, not a single point. In early-stage companies, especially high-risk sectors, intrinsic value and investor price often differ. The spread is informative, not anomalous.
Match the tool to the failure mode. Whether you are choosing a podcast recording method or a valuation method, the best approach is the one that manages the most important risk with the least unnecessary friction.

Conclusion: Value Is Not a Number, It Is a Negotiation Between Futures

The deepest lesson here is that valuation is not a search for one correct answer. It is an attempt to reconcile two futures: the future the asset can create, and the future the investor needs in order to say yes.

WACC tells you whether the business can stand as an economic organism. Target IRR tells you whether capital can justify joining that organism at a given price. Neither view is complete on its own. Together, they reveal why value is never merely found. It is framed, tested, and finally agreed upon by people who are looking at the same future through different windows.

Once you understand that, you stop treating valuation as a contest of formulas. You start treating it as a disciplined conversation about perspective, risk, and the kind of future worth paying for.